Yanyu Wu

Truven Health Analytics (United States)

Papers

1

Total Citations

18

H-Index

1

About

Yanyu Wu is a leading health services researcher whose work sits at the intersection of surgical innovation, health economics, and patient outcomes. Her most-cited study, “Robot-Assisted Surgery For Kidney Cancer Increased Access To A Procedure That Can Reduce Mortality And Renal Failure” (2015, 18 citations), critically examines the adoption of robotic technology in oncology. Wu’s research reveals a compelling paradox: while robot-assisted surgery expands access to minimally invasive procedures that lower mortality and preserve kidney function, the substantial financial investment required for robotic systems does not consistently translate into superior long-term patient outcomes under current reimbursement models. This landmark work has shaped policy discussions around value-based care and technology diffusion in surgery. Beyond this study, Wu’s broader portfolio investigates how surgical innovations affect healthcare disparities, hospital financial performance, and clinical decision-making. Her findings are essential reading for clinicians, hospital administrators, and policymakers navigating the tension between cutting-edge technology and sustainable healthcare delivery. Wu’s scholarship continues to influence how we measure success in surgical oncology—prioritizing not just what is possible, but what is truly beneficial for patients and health systems alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Surgery For Kidney Cancer Increased Access To A Procedure That Can Reduce Mortality And Renal Failure
18 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Truven Health Analytics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago